Evidence map›Paper›PMID 42888447›Full record

SynthesisSystematic reviews2026

Exploring gut microbiome dysbiosis in vasculitis in adults: a systematic review.

Kamila Hashemzadeh, Mozhdeh Ghamari, Sarah Deutsch, Andreas Schwarting, Konstantinos Triantafyllias

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Systematic reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kamila HashemzadehDepartment of Rheumatology, Acute Rheumatology Center, Bad Kreuznach, Germany.
Mozhdeh GhamariRheumatic Disease Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Sarah DeutschDivision of Rheumatology and Clinical Immunology, Department of Internal Medicine I, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstr. 1, Mainz, 55131, Germany. sadeutsc@students.uni-mainz.de.ORCID http://orcid.org/0009-0000-7555-6167
Andreas SchwartingDepartment of Rheumatology, Acute Rheumatology Center, Bad Kreuznach, Germany.
Konstantinos TriantafylliasDepartment of Rheumatology, Acute Rheumatology Center, Bad Kreuznach, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimAlthough studies have confirmed that disruptions in the gut microbiota (dysbiosis) contribute to the development of autoimmune disorders, the precise pathways through which the gut microbiota influences the onset and progression of vasculitis remain largely unknown. In recent years, research has increasingly concentrated on assessing the contribution of the gut microbiota to vasculitis. This systematic study sought to assess the dominant gut microbiota profiles in vasculitis patients and compare them to those of healthy individuals.

methodsThe Cochrane methodology was used to design and conduct the present systematic review. Relevant articles published up to May 2025 were searched and collected from four electronic databases: PubMed, Scopus, Medline, and Web of Science. The keywords used in the search included "vasculitis," "Takayasu arteritis," "giant cell arteritis," "polyarteritis nodosa," "microscopic polyangiitis," "granulomatosis with polyangiitis," "eosinophilic granulomatosis with polyangiitis," "cryoglobulinemic vasculitis," "IgA vasculitis," "variable vessel vasculitis," "Behçet's disease," and "Cogan's syndrome" alongside phrases like "gut microbiome," "gut microbiota," and "gut flora."

resultsOverall, 12 publications were included in the analysis. Three addressed individuals with Takayasu arteritis (TAK), three investigated ANCA-associated vasculitis (AAV), another three examined Behçet's disease (BD), while one study each pertained to IgA vasculitis (IgAV), Kawasaki disease (KD), and a nonspecific form of vasculitis. The majority of these works observed variations in both α-diversity and β-diversity, as well as in the diversity and richness of the gut microbiota. Additionally, the structure of the microbial communities differed markedly between those with vasculitis and healthy individuals. Notably, Bacteroidetes, Firmicutes, and Proteobacteria-the dominant bacterial phyla in the human gastrointestinal tract-were frequently diminished in affected patients.

conclusionThe occurrence of intestinal microbial imbalance in individuals diagnosed with vasculitis has been validated. As observed in various other autoimmune conditions, the gut microbiota of vasculitis patients is chiefly comprised Bacteroidetes, Firmicutes, Proteobacteria, and Actinobacteria. Disruptions in the microbial ecosystem-mainly typified by diminished diversity and population density-may play a role in triggering and advancing the disease. SYSTEMATIC REVIEW REGISTRATION: This review was not registered.

Indexed as

DysbiosisGastrointestinal MicrobiomeVasculitisAdultHumansGut microbiotaImmune inflammationShort-chain fatty acidsVasculitis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.